TABLE 1.
Vaccine groupc | Expt 1a
|
Expt 2b
|
||||
---|---|---|---|---|---|---|
Log10 CFUd | Log10 resistancee | Pf | Log10 CFU | Log10 resistance | P | |
Naive | 5.06 ± 0.04 | 5.74 ± 0.12 | ||||
DDA | 5.04 ± 0.05 | <0.05 | 5.75 ± 0.08 | <0.05 | ||
BCG | 4.33 ± 0.06 | 0.73 | 0.008 | 4.76 ± 0.18 | 0.98 | 0.008 |
ST-CF–DDA | 3.94 ± 0.08 | 1.10 | 0.008 | 4.94 ± 0.11 | 0.81 | 0.006 |
Ag85B–DDA | 4.29 ± 0.05 | 0.75 | 0.007 | NDg | ND | |
ESAT-6–DDA | 4.93 ± 0.01 | 0.11 | 5.50 ± 0.02 | 0.25 | 0.009 |
Mice received an i.v. challenge, and bacterial loads in the liver were determined.
Mice received an aerosol TB infection, and bacterial loads in the lungs were determined.
Mice were vaccinated once with BCG or three times at 2-week intervals with the subunit vaccines.
Geometric means ± standard error of the means. Data are means based on duplicate analysis of five animals in each group.
Protective efficacies of vaccines, expressed as log10 reductions in bacterial loads compared to those in the adjuvant controls.
P values are given for bacterial loads significantly different from those in control mice.
ND, not done.